Americafirst Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Americafirst Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$876K	Buy	+4,629	New	+$838K	1.18%	10

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Americafirst Capital Management's TMO Position: Q3 2017 in Review

Americafirst Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2017: 4,629 shares worth $876K. The stake represents 1.18% of the portfolio and ranks #10 among its holdings.

1,162 funds tracked by Wall St. Rank hold TMO as of Q3 2017.

Americafirst Capital Management held 4,629 shares of Thermo Fisher Scientific worth $876K as of Q3 2017.
Thermo Fisher Scientific was a new Americafirst Capital Management position in Q3 2017.
Thermo Fisher Scientific made up 1.18% of Americafirst Capital Management's portfolio in Q3 2017, its #10 holding.
1,162 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.